Canada gives full approval to J&J’s single-shot COVID-19 vaccine

Vials labeled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of the Johnson&Johnson logo displayed in this illustration, taken Feb. 9, 2021. REUTERS/Dado Ruvic/Illustration

Nov 24 (Reuters) – Johnson & Johnson (JNJ.N) said on Wednesday that Canada has given full approval to its single-shot COVID-19 vaccine for people aged 18 and older, making it the first full approval for the vaccine worldwide.

The vaccine had previously been approved by the country under an interim order. (

Canada, which reports an average of 2,563 infections each day and has administered at least 60,101,058 doses of COVID-19 vaccines to date, has given full approval to Moderna Inc. (MRNA.O) and Pfizer Incs (PFE.N) coronavirus vaccines in September.

The country this month approved the use of Pfizer’s COVID-19 vaccine for children ages 5 to 11 and a booster dose for people ages 18 and older. read more

J&J’s coronavirus vaccine is approved for emergency use in many countries, including the United States.

Register now for FREE unlimited access to

Reporting by Dania Nadeem in Bengaluru; Editing by Shounak Dasgupta

Our standards: The Thomson Reuters Trust Principles.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *